Clinical Trials Logo

Clinical Trial Summary

The United States is currently experiencing an increase in the incidence and prevalence of obstructive sleep apnea (OSA). With prevalence in middle-aged adults of 2 to 4% of the population, untreated OSA has been implicated in increased risk for cardiovascular disease, including hypertension and heart failure, daytime sleepiness, and increased risk of motor vehicle accidents. This study was design in order to evaluate the CelonProSleep plus for multi-level radiofrequency ablation (RFA) of the palate and base of tongue as a treatment for mild to moderate obstructive sleep apnea syndrome (OSAS).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02349893
Study type Interventional
Source Olympus Surgical Technologies Europe
Contact
Status Completed
Phase N/A
Start date February 2015
Completion date June 30, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04326634 - Controlled Exercises Effectiveness in Patients With Sleep Apnea N/A
Completed NCT02898792 - Remifentanil in Adults With OSA Early Phase 1
Active, not recruiting NCT04861038 - Study Using Negative Pressure to Reduce Apnea N/A
Completed NCT00252629 - Sleep Disordered Breathing in Gulf War Illness and the Effect of Nasal CPAP Treatment N/A
Completed NCT01092780 - Pharmacodynamics and Efficacy of MK-7288 in Adults With Sleep Apnea (MK-7288-010) Phase 1
Completed NCT03033901 - Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome
Completed NCT03034447 - Sleep Apnea in Asthmatic Children and Teenagers N/A
Completed NCT03172806 - Comparison of the New Algorithm of STOP-Bang in the Detection of Severe OSA Patients
Completed NCT02886156 - Effects of CPAP on Cognitive Function, Neurocognitive Architecture and Function in Patients With OSA: The SMOSAT Trial N/A